Research at NHGRI
The Division of Intramural Research conducts a broad program of laboratory and clinical research.
Share Share
Feature

FDA approves crystal-dissolving eye drops, a major milestone for NIH rare disease researchers

EyesRead the heroic story about how an experimental eye-drop solution containing a drug called cysteamine eliminates the the painful and destructive crystalline shards in the eyes of patients suffering from a rare, inherited condition called nephropathic cystinosis. Learn how the eyedrop went from clinical trial, to FDA approval and availability for use on Oct. 3, 2012, The research was spearheaded by NHGRI Clinical Director, William Gahl, M.D., Ph.D. (more)

See Also: DIR News Features

Current Topics in Genome Analysis 2012
Current Topics in Genome Analysis lecture series consists of lectures by local and outside speakers covering the major areas of genomics.

Highlights

NIH researchers study microbial shift between healthy children and adults

Genome Medicine magazine Julie Segre, Ph.D., NHGRI Genetics and Molecular Biology Branch senior investigator, and colleagues at the National Cancer Institute report in the Oct. 10, 2012 advance online issue of Genome Medicine that bacterial communities in chidren's nasal passages differ strikingly from those of adults. The authors suggest that these shifts in the skin microbiome may be relevant to prevention, diagnosis and treatment strategies of disorders like atopic dermatitis.
Read the study: Shifts in human skin and nares microbiota of healthy children and adults [genomemedicine.com]
Recent Studies and Papers

Last Updated: October 11, 2012